COMMUNIQUÉS West-GlobeNewswire

Harrow Announces Second-Quarter 2025 Financial Results
11/08/2025
Second-Quarter 2025 and Recent Selected Highlights: Total revenues of $63.7 million, a 30% increase over $48.9 million recorded in the prior-year period GAAP net income of $5.0 million Adjusted EBITDA of $17.0 million [...]
Standard BioTools Reports Second Quarter 2025 Financial Results
11/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the second quarter ended June 30, 2025. [...]
Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
11/08/2025
FDA accepts NDA submission for Anaphylm™; PDUFA date set for January 31, 2026 Planning continues for a Q1 2026 U.S. launch of Anaphylm, if approved by the FDA Company accelerates Anaphylm global expansion strategy to [...]
Olema Oncology Reports Second Quarter 2025 Financial and Operating Results
11/08/2025
Selected 90 mg once-daily palazestrant for Part 2 of the OPERA-01 Phase 3 monotherapy trial and for the OPERA-02 Phase 3 trial in combination with ribociclib OPERA-01 enrollment ongoing with top-line data expected in [...]

Pages